The Recombinant Vaccines Market size was USD 9.94 Billion in 2023 and is expected to Reach USD 23.75 Billion by 2031 and grow at a CAGR of 11.5% over the forecast period of 2024-2031.The recombinant vaccines market is witnessing significant growth, driven by advancements in genetic engineering and biotechnology. These vaccines, which utilize recombinant DNA technology to produce antigens...
The Recombinant Vaccines Market in 2023 is US$ 10.09 billion, and is expected to reach US$ 24.32 billion by 2031 at a CAGR of 11.60%.
FutureWise Research published a report that analyzes Recombinant Vaccines Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the...
The global recombinant vaccines market size was valued at USD 11,507.3 million in 2021 and is poised to grow at a significant CAGR of 5.3% during the forecast period 2022-28. Increased prevalence of infectious diseases and increased technological advancements boost the growth of the recombinant vaccine market. Furthermore, increased regulatory approvals of recombinant vaccines also drive the...
Bharat Book Bureau Provides the Trending Market Research Report on “Global Recombinant Vaccines Market Report and Forecast 2023-2031” under Life Sciences Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports.
The value of the global Recombinant Vaccine Market was USD 13.32 billion in...